Chaturvedi V.K. Singh A. Singh V.K. Singh M.P. Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy CDM 2019 20 416 429 10.2174/1389200219666180918111528 30227814
Zhang Y. Li M. Gao X. Chen Y. Liu T. Nanotechnology in cancer diagnosis: Progress, challenges and opportunities J. Hematol. Oncol. 2019 12 137 10.1186/s13045-019-0833-3 31847897
Wáng Y.X.J. Idée J.-M. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging Quant. Imaging Med. Surg. 2017 7 88 122 10.21037/qims.2017.02.09 28275562
Zhao K. Detection of gadolinium deposition in cortical bone with ultrashort echo time T1 mapping: An ex vivo study in a rabbit model Eur. Radiol. 2020 31 1569 1577 10.1007/s00330-020-07258-x
Do C. DeAguero J. Brearley A. Trejo X. Howard T. Escobar G.P. Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution Kidney360 2020 1 561 568 10.34067/KID.0000272019
Le Fur M. Caravan P. The biological fate of gadolinium-based MRI contrast agents: A call to action for bioinorganic chemists Metallomics 2019 11 240 254 10.1039/C8MT00302E
Jeon M. Halbert M.V. Stephen Z.R. Zhang M. Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives Adv. Mater. 2020 33 1906539 10.1002/adma.201906539
Fernández-Barahona I. Muñoz-Hernando M. Ruiz-Cabello J. Herranz F. Pellico J. Iron Oxide Nanoparticles: An Alternative for Positive Contrast in Magnetic Resonance Imaging Inorganics 2020 8 28 10.3390/inorganics8040028
Chandrasekharan P. Tay Z.W. Hensley D. Zhou X.Y. Fung B.K. Colson C. Lu Y. Fellows B.D. Huynh Q. Saayujya C. et al. Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: Tracers, hardware, and future medical applications Theranostics 2020 10 2965 2981 10.7150/thno.40858
Bulte J.W.M. Superparamagnetic iron oxides as MPI tracers: A primer and review of early applications Adv. Drug Deliv. Rev. 2019 138 293 301 10.1016/j.addr.2018.12.007
Rubia-Rodríguez I. Santana-Otero A. Spassov S. Tombácz E. Johansson C. Thanh N.T.K. Besenhard M.O. Wilhelm C. Gazeau F. Harmer Q. et al. Whither Magnetic Hyperthermia? A Tentative Roadmap Materials 2021 14 706 10.3390/ma14040706
Goss C.J. Saturation Magnetisation, Coercivity and Lattice Parameter Changes in the System Fe3O4-yF2O3, and Their Relationship to Structure Phys. Chem. Miner. 1988 16 164 171 10.1007/BF00203200
Issa B. Obaidat I.M. Magnetic Nanoparticles as MRI Contrast Agents Magnetic Resonance Imaging Manchev L. IntechOpen London, UK 2019 Available online: https://www.intechopen.com/books/magnetic-resonance-imaging/magnetic-nanoparticles-as-mri-contrast-agents (accessed on 2 December 2022)
Cornell R.M. Schwertmann U. The Iron Oxides: Structure, Properties, Reactions, Occurences and Uses 1st ed. Wiley New York, NY, USA 2003 Available online: https://onlinelibrary.wiley.com/doi/book/10.1002/3527602097 (accessed on 5 March 2021)
Girardet T. Venturini P. Martinez H. Dupin J.-C. Cleymand F. Fleutot S. Spinel Magnetic Iron Oxide Nanoparticles: Properties, Synthesis and Washing Methods Appl. Sci. 2022 12 8127 10.3390/app12168127
Wallyn; Anton; Vandamme Synthesis, Principles, and Properties of Magnetite Nanoparticles for In Vivo Imaging Applications—A Review Pharmaceutics 2019 11 601 10.3390/pharmaceutics11110601
Jin R. Lin B. Li D. Ai H. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: Design considerations and clinical applications Curr. Opin. Pharmacol. 2014 18 18 27 10.1016/j.coph.2014.08.002
Dulińska-Litewka J. Łazarczyk A. Hałubiec P. Szafrański O. Karnas K. Karewicz A. Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications Materials 2019 12 617 10.3390/ma12040617
Wahajuddin Arora S. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers Int. J. Nanomed. 2012 7 3445 3471 10.2147/IJN.S30320
LaMer V.K. Dinegar R.H. Theory, Production and Mechanism of Formation of Monodispersed Hydrosols J. Am. Chem. Soc. 1950 72 4847 4854 10.1021/ja01167a001
You H. Fang J. Particle-mediated nucleation and growth of solution-synthesized metal nanocrystals: A new story beyond the LaMer curve Nano Today 2016 11 145 167 10.1016/j.nantod.2016.04.003
Thanh N.T.K. Maclean N. Mahiddine S. Mechanisms of Nucleation and Growth of Nanoparticles in Solution Chem. Rev. 2014 114 7610 7630 10.1021/cr400544s
Stanicki D. Vangijzegem T. Ternad I. Laurent S. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery Expert Opin. Drug Deliv. 2022 19 321 335 10.1080/17425247.2022.2047020 35202551
Oehlsen O. Cervantes-Ramírez S.I. Cervantes-Avilés P. Medina-Velo I.A. Approaches on Ferrofluid Synthesis and Applications: Current Status and Future Perspectives ACS Omega 2022 7 3134 3150 10.1021/acsomega.1c05631 35128226
Stanicki D. Elst L.V. Muller R.N. Laurent S. Synthesis and processing of magnetic nanoparticles Curr. Opin. Chem. Eng. 2015 8 7 14 10.1016/j.coche.2015.01.003
Xie W. Guo Z. Gao F. Gao Q. Wang D. Liaw B. Cai Q. Sun X. Wang X. Zhao L. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics Theranostics 2018 8 3284 3307 10.7150/thno.25220 29930730
Kwon H.J. Shin K. Soh M. Chang H. Kim J. Lee J. Ko G. Kim B.H. Kim D. Hyeon T. Large-Scale Synthesis and Medical Applications of Uniform-Sized Metal Oxide Nanoparticles Adv. Mater. 2018 30 1704290 10.1002/adma.201704290 29573296
Salvador M. Moyano A. Martínez-García J.C. Blanco-López M.C. Rivas M. Synthesis of Superparamagnetic Iron Oxide Nanoparticles: SWOT Analysis towards Their Conjugation to Biomolecules for Molecular Recognition Applications J. Nanosci. Nanotechnol. 2019 19 4839 4856 10.1166/jnn.2019.16931
Dlugosz O. Banach M. Inorganic nanoparticle synthesis in flow reactors—Applications and future directions React. Chem. Eng. 2020 5 1619 1641 10.1039/D0RE00188K
Hassan N. Oyarzun-Ampuero F. Lara P. Guerrero S. Cabuil V. Abou-Hassan A. Kogan M. Flow Chemistry to Control the Synthesis of Nano and Microparticles for Biomedical Applications Curr. Top. Med. Chem. 2014 14 676 689 10.2174/1568026614666140118213915
Skrabalak S.E. Brutchey R.L. Going with the Flow: Continuous Flow Routes to Colloidal Nanoparticles Chem. Mater. 2016 28 1003 1005 10.1021/acs.chemmater.6b00472
Vangijzegem T. Stanicki D. Panepinto A. Socoliuc V. Vekas L. Muller R.N. Laurent S. Influence of Experimental Parameters of a Continuous Flow Process on the Properties of Very Small Iron Oxide Nanoparticles (VSION) Designed for T1-Weighted Magnetic Resonance Imaging (MRI) Nanomaterials 2020 10 757 10.3390/nano10040757
Besenhard M.O. LaGrow A.P. Famiani S. Pucciarelli M. Lettieri P. Thanh N.T.K. Gavriilidis A. Continuous production of iron oxide nanoparticles via fast and economical high temperature synthesis React. Chem. Eng. 2020 5 1474 1483 10.1039/D0RE00078G
Jiao M. Zeng J. Jing L. Liu C. Gao M. Flow Synthesis of Biocompatible Fe3O4 Nanoparticles: Insight into the Effects of Residence Time, Fluid Velocity, and Tube Reactor Dimension on Particle Size Distribution Chem. Mater. 2015 27 1299 1305 10.1021/cm504313c
Besenhard M.O. LaGrow A.P. Hodzic A. Kriechbaum M. Panariello L. Bais G. Loizou K. Damilos S. Margarida Cruz M. Thanh N.T.K. et al. Co-precipitation synthesis of stable iron oxide nanoparticles with NaOH: New insights and continuous production via flow chemistry Chem. Eng. J. 2020 399 125740 10.1016/j.cej.2020.125740
Santoyo Salazar J. Perez L. de Abril O. Truong Phuoc L. Ihiawakrim D. Vazquez M. Greneche J.-M. Begin-Colin S. Pourroy G. Magnetic Iron Oxide Nanoparticles in 10–40 nm Range: Composition in Terms of Magnetite/Maghemite Ratio and Effect on the Magnetic Properties Chem. Mater. 2011 23 1379 1386 10.1021/cm103188a
Liang Y. Xie J. Yu J. Zheng Z. Liu F. Yang A. Recent advances of high performance magnetic iron oxide nanoparticles: Controlled synthesis, properties tuning and cancer theranostics Nano Sel. 2021 2 216 250 10.1002/nano.202000169
Nichols J.W. Bae Y.H. EPR: Evidence and fallacy J. Control. Release 2014 190 451 464 10.1016/j.jconrel.2014.03.057
Wu J. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application J. Pers. Med. 2021 11 771 10.3390/jpm11080771
Fang J. Islam W. Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers Adv. Drug Deliv. Rev. 2020 157 142 160 10.1016/j.addr.2020.06.005
Toy R. Peiris P.M. Ghaghada K.B. Karathanasis E. Shaping cancer nanomedicine: The effect of particle shape on the in vivo journey of nanoparticles Nanomedicine 2014 9 121 134 10.2217/nnm.13.191
Roca A.G. Gutiérrez L. Gavilán H. Fortes Brollo M.E. Veintemillas-Verdaguer S. del Puerto Moralesa M. Design strategies for shape-controlled magnetic iron oxide nanoparticles Adv. Drug Deliv. Rev. 2019 138 68 104 10.1016/j.addr.2018.12.008
Yang L. Wang Z. Ma L. Li A. Xin J. Wei R. Lin H. Wang R. Chen Z. Gao J. The Roles of Morphology on the Relaxation Rates of Magnetic Nanoparticles ACS Nano 2018 12 4605 4614 10.1021/acsnano.8b01048
Truong N.P. Whittaker M.R. Mak C.W. Davis T.P. The importance of nanoparticle shape in cancer drug delivery Expert Opin. Drug Deliv. 2015 12 129 142 10.1517/17425247.2014.950564
Yang T. Zhai J. Hu D. Yang R. Wang G. Li Y. Liang G. “Targeting Design” of Nanoparticles in Tumor Therapy Pharmaceutics 2022 14 1919 10.3390/pharmaceutics14091919
Jindal A.B. The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles Int. J. Pharm. 2017 532 450 465 10.1016/j.ijpharm.2017.09.028
Naumenko V. Garanina A. Nikitin A. Vodopyanov S. Vorobyeva N. Tsareva Y. Kunin M. Ilyasov A. Semkina A. Chekhonin V. et al. Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models Contrast Media Mol. Imaging 2018 2018 8264208 10.1155/2018/8264208
Ohshima M. The Derjaguin-Landau-Verwey-Overbeek (DLVO) Theory of Colloid Stability Electrical Phenomena at Interfaces and Biointerfaces: Fundamentals and Applications in Nano-, Bio-, and Environmental Sciences John Wiley & Sons, Inc. Hoboken, NJ, USA 2012 8
Pušnik K. Peterlin M. Kralj-Cigic I. Marolt G. Kogej K. Mertelj A. Gyergyek S. Makovec D. Adsorption of Amino Acids, Aspartic Acid and Lysine onto Iron-Oxide Nanoparticles J. Phys. Chem. 2016 120 14372 14381 10.1021/acs.jpcc.6b03180
Răcuciu M. Barbu-Tudoran L. Oancea S. Drăghici O. Morosanu C. Grigoras M. Brînză F. Creangă D.E. Aspartic Acid Stabilized Iron Oxide Nanoparticles for Biomedical Applications Nanomaterials 2022 12 1151 10.3390/nano12071151
Boyer C. Whittaker M.R. Bulmus V. Liu J. Davis T.P. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications NPG Asia Mater. 2010 2 23 30 10.1038/asiamat.2010.6
Mishra P. Nayak B. Dey R.K. PEGylation in anti-cancer therapy: An overview Asian J. Pharm. Sci. 2016 11 337 348 10.1016/j.ajps.2015.08.011
Suk J.S. Xu Q. Kim N. Hanes J. Ensign L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery Adv. Drug Deliv. Rev. 2016 99 28 51 10.1016/j.addr.2015.09.012
Wani T.U. Raza S.N. Khan N.A. Nanoparticle opsonization: Forces involved and protection by long chain polymers Polym. Bull. 2020 77 3865 3889 10.1007/s00289-019-02924-7
Xue W. Liu Y. Zhang N. Yao Y. Ma P. Wen H. Huang S. Luo Y.E. Fan H. Effects of core size and PEG coating layer of iron oxide nanoparticles on the distribution and metabolism in mice Int. J. Nanomed. 2018 13 5719 5731 10.2147/IJN.S165451
Lazaro-Carrillo A. Filice M. Guillén M.J. Amaro R. Viñambres M. Tabero A. Paredes K.O. Villanueva A. Calvo P. del Puerto Morales M. et al. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers Mater. Sci. Eng. C 2020 107 110262 10.1016/j.msec.2019.110262
Stanicki D. Larbanoix L. Boutry S. Vangijzegem T. Ternad I. Garifo S. Muller R.N. Laurent S. Impact of the chain length on the biodistribution profiles of PEGylated iron oxide nanoparticles: A multimodal imaging study J. Mater. Chem. B 2021 9 5055 5068 10.1039/D1TB00573A
Sharifi S. Caracciolo G. Mahmoudi M. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers Trends Pharmacol. Sci. 2020 41 641 652 10.1016/j.tips.2020.06.011
Li H. Wang Y. Tang Q. Yin D. Tang C. He E. Zou L. Peng Q. The protein corona and its effects on nanoparticle-based drug delivery systems Acta Biomater. 2021 129 57 72 10.1016/j.actbio.2021.05.019
García-Álvarez R. Vallet-Regí M. Hard and Soft Protein Corona of Nanomaterials: Analysis and Relevance Nanomaterials 2021 11 888 10.3390/nano11040888
Frtús A. Smolková B. Uzhytchak M. Lunova M. Jirsa M. Kubinová Š. Dejneka A. Lunov O. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications J. Control. Release 2020 328 59 77 10.1016/j.jconrel.2020.08.036
Park S.J. Protein–Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles Int. J. Nanomed. 2020 15 5783 5802 10.2147/IJN.S254808
Ke P.C. Lin S. Parak W.J. Davis T.P. Caruso F. A Decade of the Protein Corona ACS Nano 2017 11 11773 11776 10.1021/acsnano.7b08008
Peng Q. Liu J. Zhang T. Zhang T.-X. Zhang C.-L. Mu H. Digestive Enzyme Corona Formed in the Gastrointestinal Tract and Its Impact on Epithelial Cell Uptake of Nanoparticles Biomacromolecules 2019 20 1789 1797 10.1021/acs.biomac.9b00175
Akhter M.H. Khalilullah H. Gupta M. Alfaleh M.A. Alhakamy N.A. Riadi Y. Md S. Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu Biomedicines 2021 9 1496 10.3390/biomedicines9101496
Nowak-Jary J. Machnicka B. Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications J. Nanobiotechnol. 2022 20 305 10.1186/s12951-022-01510-w
Gupta P. Lakes A. Dziubla T. Chapter One—A Free Radical Primer Oxidative Stress and Biomaterials Dziubla T. Butterfield D.A. Academic Press Cambridge, MA, USA 2016 1 33 978-0-12-803269-5
Pérez-Herrero E. Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy Eur. J. Pharm. Biopharm. 2015 93 52 79 10.1016/j.ejpb.2015.03.018
Tewabe A. Abate A. Tamrie M. Seyfu A. Abdela Siraj E. Targeted Drug Delivery—From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives J. Multidiscip. Healthc. 2021 14 1711 1724 10.2147/JMDH.S313968
Schleich N. Sibret P. Danhier P. Ucakar B. Laurent S. Muller R.N. Jérôme C. Gallez B. Préat V. Danhier F. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int. J. Pharm. 2013 447 94 101 10.1016/j.ijpharm.2013.02.042
Quan Q. Xie J. Gao H. Yang M. Zhang F. Liu G. Lin X. Wang A. Eden H.S. Lee S. et al. HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy Mol. Pharm. 2011 8 1669 1676 10.1021/mp200006f
Zhao S. Yu X. Qian Y. Chen W. Shen J. Multifunctional magnetic iron oxide nanoparticles: An advanced platform for cancer theranostics Theranostics 2020 10 6278 6309 10.7150/thno.42564
Yue L. Sun C. Kwong C.H.T. Wang R. Cucurbit[7]uril-functionalized Magnetic Nanoparticles for Imaging-guided Cancer Therapy J. Mater. Chem. B 2020 8 2749 2753 10.1039/D0TB00306A
Tay Z.W. Chandrasekharan P. Zhou X.Y. Yu E. Zheng B. Conolly S. In vivo tracking and quantification of inhaled aerosol using magnetic particle imaging towards inhaled therapeutic monitoring Theranostics 2018 8 3676 3687 10.7150/thno.26608
Tomitaka A. Arami H. Huang Z. Raymond A. Rodriguez E. Cai Y. Febo M. Takemura Y. Nair M. Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment Nanoscale 2018 10 184 194 10.1039/C7NR07255D
Stueber D.D. Villanova J. Aponte I. Xiao Z. Colvin V.L. Magnetic Nanoparticles in Biology and Medicine: Past, Present, and Future Trends Pharmaceutics 2021 13 943 10.3390/pharmaceutics13070943
Jung K.O. Jo H. Yu J.H. Gambhir S.S. Pratx G. Development and MPI tracking of novel hypoxia-targeted theranostic exosomes Biomaterials 2018 177 139 148 10.1016/j.biomaterials.2018.05.048
Liang X. Wang K. Du J. Tian J. Zhang H. The first visualization of chemotherapy-induced tumor apoptosis via magnetic particle imaging in a mouse model Phys. Med. Biol. 2020 65 195004 10.1088/1361-6560/abad7c
Zhu X. Li J. Peng P. Hosseini Nassab N. Smith B.R. Quantitative Drug Release Monitoring in Tumors of Living Subjects by Magnetic Particle Imaging Nanocomposite Nano Lett. 2019 19 6725 6733 10.1021/acs.nanolett.9b01202
Cheng Z. Li M. Dey R. Chen Y. Nanomaterials for cancer therapy: Current progress and perspectives J. Hematol. Oncol. 2021 14 85 10.1186/s13045-021-01096-0
Narum S.M. Le T. Le D.P. Lee J.C. Donahue N.D. Yang W. Wilhelm S. Passive targeting in nanomedicine: Fundamental concepts, body interactions, and clinical potential Nanoparticles for Biomedical Applications Elsevier Amsterdam, The Netherlands 2020 37 53
Nosrati R. Abnous K. Alibolandi M. Mosafer J. Dehghani S. Taghdisi S.M. Ramezani M. Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma Sci. Rep. 2021 11 13065 10.1038/s41598-021-92391-w
Jia G. Han Y. An Y. Ding Y. He C. Wang X. Tang Q. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo Biomaterials 2018 178 302 316 10.1016/j.biomaterials.2018.06.029
Qi H. Liu C. Long L. Ren Y. Zhang S. Chang X. Qian X. Jia H. Zhao J. Sun J. et al. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy ACS Nano 2016 10 3323 3333 10.1021/acsnano.5b06939
De Lavera I. Merkling P.J. Oliva J.M. Sayagués M.J. Cotán D. Sánchez-Alcázar J.A. Infante J.J. Zaderenko A.P. EGFR-targeting antitumor therapy: Neuregulins or antibodies? Eur. J. Pharm. Sci. 2021 158 105678 10.1016/j.ejps.2020.105678
Zhu J.-Y. Zheng D.-W. Zhang M.-K. Yu W.-Y. Qiu W.-X. Hu J.-J. Feng J. Zhang X.-Z. Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes Nano Lett. 2016 16 5895 5901 10.1021/acs.nanolett.6b02786 27513184
Meng X. Wang J. Zhou J. Tian Q. Qie B. Zhou G. Duan W. Zhu Y. Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis Acta Biomater. 2021 127 266 275 10.1016/j.actbio.2021.03.056 33813091
Zhu K. Deng Z. Liu G. Hu J. Liu S. Photoregulated Cross-Linking of Superparamagnetic Iron Oxide Nanoparticle (SPION) Loaded Hybrid Nanovectors with Synergistic Drug Release and Magnetic Resonance (MR) Imaging Enhancement Macromolecules 2017 50 1113 1125 10.1021/acs.macromol.6b02162
Zhao W. Odelius K. Edlund U. Zhao C. Albertsson A.-C. In Situ Synthesis of Magnetic Field-Responsive Hemicellulose Hydrogels for Drug Delivery Biomacromolecules 2015 16 2522 2528 10.1021/acs.biomac.5b00801 26196600
Nowak B.P. Niehues M. Ravoo B.J. Magneto-responsive hydrogels by self-assembly of low molecular weight peptides and crosslinking with iron oxide nanoparticles Soft Matter 2021 17 2857 2864 10.1039/D0SM02049D 33586750
Ayyanaar S. Balachandran C. Bhaskar R.C. Kesavan M.P. Aoki S. Raja R.P. Rajesh J. Webster T.J. Rajagopal G. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy Int. J. Nanomed. 2020 15 3333 3346 10.2147/IJN.S249240
Liu J. Liu W. Zhang K. Shi J. Zhang Z. A Magnetic Drug Delivery System with “OFF–ON” State via Specific Molecular Recognition and Conformational Changes for Precise Tumor Therapy Adv. Healthc. Mater. 2020 9 1901316 10.1002/adhm.201901316
Cai M. Li B. Lin L. Huang J. An Y. Huang W. Zhou Z. Wang Y. Shuai W. Zhu K. A reduction and pH dual-sensitive nanodrug for targeted theranostics in hepatocellular carcinoma Biomater. Sci. 2020 8 3485 3499 10.1039/D0BM00295J
Ding X. Jiang W. Dong L. Hong C. Luo Z. Hu Y. Cai K. Redox-responsive magnetic nanovectors self-assembled from amphiphilic polymer and iron oxide nanoparticles for a remotely targeted delivery of paclitaxel J. Mater. Chem. B 2021 9 6037 6043 10.1039/D1TB00991E
Turiel-Fernández D. Gutiérrez-Romero L. Corte-Rodriguez M. Bettmer J. Montes-Bayón M. Ultrasmall iron oxide nanoparticles cisplatin (IV) prodrug nanoconjugate: ICP-MS based strategies to evaluate the formation and drug delivery capabilities in single cells Anal. Chim. Acta 2021 1159 338356 10.1016/j.aca.2021.338356
Hannecart A. Stanicki D. Vander Elst L. Muller R.N. Lecommandoux S. Thévenot J. Bonduelle C. Trotier A. Massot P. Miraux S. et al. Nano-thermometers with thermo-sensitive polymer grafted USPIOs behaving as positive contrast agents in low-field MRI Nanoscale 2015 7 3754 3767 10.1039/C4NR07064J
Sharif S. Nguyen K.T. Bang D. Park J.-O. Choi E. Optimization of Field-Free Point Position, Gradient Field and Ferromagnetic Polymer Ratio for Enhanced Navigation of Magnetically Controlled Polymer-Based Microrobots in Blood Vessel Micromachines 2021 12 424 10.3390/mi12040424
Wu Z. Li T. Li J. Gao W. Xu T. Christianson C. Gao W. Galarnyk M. He Q. Zhang L. et al. Turning Erythrocytes into Functional Micromotors ACS Nano 2014 8 12041 12048 10.1021/nn506200x
Kim D. Lee H. Kwon S. Sung Y.J. Song W.K. Park S. Bilayer Hydrogel Sheet-Type Intraocular Microrobot for Drug Delivery and Magnetic Nanoparticles Retrieval Adv. Healthc. Mater. 2020 9 2000118 10.1002/adhm.202000118
Naud C. Thébault C. Carrière M. Hou Y. Morel R. Berger F. Diény B. Joisten H. Cancer treatment by magneto-mechanical effect of particles, a review Nanoscale Adv. 2020 2 3632 3655 10.1039/D0NA00187B
Li W. Liu Y. Qian Z. Yang Y. Evaluation of Tumor Treatment of Magnetic Nanoparticles Driven by Extremely Low Frequency Magnetic Field Sci. Rep. 2017 7 46287 10.1038/srep46287
Lopez S. Hallali N. Lalatonne Y. Hillion A. Antunes J.C. Serhan N. Clerc P. Fourmy D. Motte L. Carrey J. et al. Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields Nanoscale Adv. 2022 4 421 436 10.1039/D1NA00474C
Martínez-Banderas A.I. Aires A. Teran F.J. Perez J.E. Cadenas J.F. Alsharif N. Ravasi T. Cortajarena A.L. Kosel J. Functionalized magnetic nanowires for chemical and magneto-mechanical induction of cancer cell death Sci. Rep. 2016 6 35786 10.1038/srep35786
Guo Y. Yang W. Pu G. Zhu C. Zhu Y. Li J. Huang Y. Wang B. Chu M. Low frequency vibrating magnetic field-triggered magnetic microspheres with a nanoflagellum-like surface for cancer therapy J. Nanobiotechnol. 2022 20 316 10.1186/s12951-022-01521-7
Hergt R. Dutz S. Magnetic particle hyperthermia—Biophysical limitations of a visionary tumour therapy J. Magn. Magn. Mater. 2007 311 187 192 10.1016/j.jmmm.2006.10.1156
Cellai F. Munnia A. Viti J. Doumett S. Ravagli C. Ceni E. Mello T. Polvani S. Giese R.W. Baldi G. et al. Magnetic Hyperthermia and Oxidative Damage to DNA of Human Hepatocarcinoma Cells Int. J. Mol. Sci. 2017 18 939 10.3390/ijms18050939 28468256
Alvarez-Berríos M.P. Castillo A. Mendéz J. Soto O. Rinaldi C. Torres-Lugo M. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity Int. J. Nanomed. 2013 8 1003 1013 10.2147/IJN.S38842
Wong D.W. Gan W.L. Teo Y.K. Lew W.S. Interplay of cell death signaling pathways mediated by alternating magnetic field gradient Cell Death Discov. 2018 4 49 10.1038/s41420-018-0052-7 29736266
Beola L. Asín L. Roma-Rodrigues C. Fernández-Afonso Y. Fratila R.M. Serantes D. Ruta S. Chantrell R.W. Fernandes A.R. Baptista P.V. et al. The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment ACS Appl. Mater. Interfaces 2020 12 43474 43487 10.1021/acsami.0c12900 32870658
Clerc P. Jeanjean P. Hallali N. Gougeon M. Pipy B. Carrey J. Fourmy D. Gigoux V. Targeted Magnetic Intra-Lysosomal Hyperthermia produces lysosomal reactive oxygen species and causes Caspase-1 dependent cell death J. Control. Release 2018 270 120 134 10.1016/j.jconrel.2017.11.050
Salimi M. Sarkar S. Hashemi M. Saber R. Treatment of Breast Cancer-Bearing BALB/c Mice with Magnetic Hyperthermia using Dendrimer Functionalized Iron-Oxide Nanoparticles Nanomaterials 2020 10 2310 10.3390/nano10112310
Boitard C. Michel A. Ménager C. Griffete N. Protein Denaturation Through the Use of Magnetic Molecularly Imprinted Polymer Nanoparticles Molecules 2021 26 3980 10.3390/molecules26133980
Pan J. Xu Y. Wu Q. Hu P. Shi J. Mild Magnetic Hyperthermia-Activated Innate Immunity for Liver Cancer Therapy J. Am. Chem. Soc. 2021 143 8116 8128 10.1021/jacs.1c02537
Carter T.J. Agliardi G. Lin F.-Y. Ellis M. Jones C. Robson M. Richard-Londt A. Southern P. Lythgoe M. Zaw Thin M. et al. Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation Small 2021 17 e2005241 10.1002/smll.202005241
Kandasamy G. Sudame A. Bhati P. Chakrabarty A. Maity D. Systematic investigations on heating effects of carboxyl-amine functionalized superparamagnetic iron oxide nanoparticles (SPIONs) based ferrofluids for in vitro cancer hyperthermia therapy J. Mol. Liq. 2018 256 224 237 10.1016/j.molliq.2018.02.029
Hedayatnasab Z. Abnisa F. Daud W.M.A.W. Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application Mater. Des. 2017 123 174 196 10.1016/j.matdes.2017.03.036
Pucci C. Degl’Innocenti A. Gümüş M.B. Ciofani G. Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: Recent advancements, molecular effects, and future directions in the omics era Biomater. Sci. 2022 10 2103 2121 10.1039/D1BM01963E
Kowalik P. Mikulski J. Borodziuk A. Duda M. Kamińska I. Zajdel K. Rybusinski J. Szczytko J. Wojciechowski T. Sobczak K. et al. Yttrium-Doped Iron Oxide Nanoparticles for Magnetic Hyperthermia Applications J. Phys. Chem. C 2020 124 6871 6883 10.1021/acs.jpcc.9b11043
Phong L.T.H. Manh D.H. Nam P.H. Lam V.D. Khuyen B.X. Tung B.S. Bach T.N. Tung D.K. Phuc N.X. Hung T.V. et al. Structural, magnetic and hyperthermia properties and their correlation in cobalt-doped magnetite nanoparticles RSC Adv. 2022 12 698 707 10.1039/D1RA07407E
Legge C.J. Colley H.E. Lawson M.A. Rawlings A.E. Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer J. Oral Pathol. Med. 2019 48 803 809 10.1111/jop.12921
Chen W. Cheng C.-A. Zink J.I. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation ACS Nano 2019 13 1292 1308 10.1021/acsnano.8b06655
El-Boubbou K. Lemine O.M. Ali R. Huwaizi S.M. Al-Humaid S. AlKushi A. Evaluating magnetic and thermal effects of various Polymerylated magnetic iron oxide nanoparticles for combined chemo-hyperthermia New J. Chem. 2022 46 5489 5504 10.1039/D1NJ05791J
Sabouri Z. Labbaf S. Karimzadeh F. Baharlou-Houreh A. McFarlane T.V. Esfahani M.H.N. Fe3O4/bioactive glass nanostructure: A promising therapeutic platform for osteosarcoma treatment Biomed. Mater. 2021 16 035016 10.1088/1748-605X/aba7d5
Mulens-Arias V. Rojas J.M. Barber D.F. The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment Front. Immunol. 2021 12 693709 10.3389/fimmu.2021.693709
Lin Y. Xu J. Lan H. Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications J. Hematol. Oncol. 2019 12 76 10.1186/s13045-019-0760-3
Nascimento C.S. Alves É.A.R. de Melo C.P. Corrêa-Oliveira R. Calzavara-Silva C.E. Immunotherapy for cancer: Effects of iron oxide nanoparticles on polarization of tumor-associated macrophages Nanomedicine 2021 16 2633 2650 10.2217/nnm-2021-0255 34854309
Canese R. Vurro F. Marzola P. Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy Nanomaterials 2021 11 1950 10.3390/nano11081950
Reichel D. Tripathi M. Perez J.M. Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment Nanotheranostics 2019 3 66 88 10.7150/ntno.30052 30662824
Zanganeh S. Hutter G. Spitler R. Lenkov O. Mahmoudi M. Shaw A. Pajarinen J.S. Nejadnik H. Goodman S. Moseley M. et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues Nat. Nanotechnol. 2016 11 986 994 10.1038/nnano.2016.168 27668795
Zhang W. Cao S. Liang S. Tan C.H. Luo B. Xu X. Saw P.E. Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages Front. Bioeng. Biotechnol. 2020 8 537 10.3389/fbioe.2020.00537 32548111
Gu Z. Liu T. Tang J. Yang Y. Song H. Tuong Z.K. Fu J. Yu C. Mechanism of Iron Oxide-Induced Macrophage Activation: The Impact of Composition and the Underlying Signaling Pathway J. Am. Chem. Soc. 2019 141 6122 6126 10.1021/jacs.8b10904
Li K. Lu L. Xue C. Liu J. He Y. Zhou J. Xia Z. Dai L. Luo Z. Mao Y. et al. Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo Nanoscale 2020 12 130 144 10.1039/C9NR06505A
Liu L. Sha R. Yang L. Zhao X. Zhu Y. Gao J. Zhang Y. Wen L.-P. Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages ACS Appl. Mater. Interfaces 2018 10 41197 41206 10.1021/acsami.8b17474
Zafar H. Raza F. Ma S. Wei Y. Zhang J. Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy Biomater. Sci. 2021 9 5092 5115 10.1039/D1BM00721A
Gao J. Zhou H. Zhao Y. Lu L. Zhang J. Cheng W. Song X. Zheng Y. Chen C. Tang J. Time-course effect of ultrasmall superparamagnetic iron oxide nanoparticles on intracellular iron metabolism and ferroptosis activation Nanotoxicology 2021 15 366 379 10.1080/17435390.2021.1872112
Yang Y. Wang Y. Guo L. Gao W. Tang T.-L. Yan M. Interaction between macrophages and ferroptosis Cell Death Dis. 2022 13 355 10.1038/s41419-022-04775-z
Wen J. Chen H. Ren Z. Zhang P. Chen J. Jiang S. Ultrasmall iron oxide nanoparticles induced ferroptosis via Beclin1/ATG5-dependent autophagy pathway Nano Converg. 2021 8 10 10.1186/s40580-021-00260-z
Fernández-Acosta R. Iriarte-Mesa C. Alvarez-Alminaque D. Hassannia B. Wiernicki B. Díaz-García A.M. Vandenabeele P. Vanden Berghe T. Pardo Andreu G.L. Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines Molecules 2022 27 3970 10.3390/molecules27133970
Iriarte-Mesa C. Díaz-Castañón S. Abradelo D.G. Facile immobilization of Trametes versicolor laccase on highly monodisperse superparamagnetic iron oxide nanoparticles Colloids Surf. B Biointerfaces 2019 181 470 479 10.1016/j.colsurfb.2019.05.012
Wu C. Shen Z. Lu Y. Sun F. Shi H. p53 Promotes Ferroptosis in Macrophages Treated with Fe3O4 Nanoparticles ACS Appl. Mater. Interfaces 2022 14 42791 42803 10.1021/acsami.2c00707
Sullivan K.D. Galbraith M.D. Andrysik Z. Espinosa J.M. Mechanisms of transcriptional regulation by p53 Cell Death Differ. 2018 25 133 143 10.1038/cdd.2017.174
Zhang C. Bu W. Ni D. Zhang S. Li Q. Yao Z. Zhang J. Yao H. Wang Z. Shi J. Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction Angew. Chem. Int. Ed. 2016 55 2101 2106 10.1002/anie.201510031
Ye S. Hananya N. Green O. Chen H. Zhao A.Q. Shen J. Shabat D. Yang D. A Highly Selective and Sensitive Chemiluminescent Probe for Real-Time Monitoring of Hydrogen Peroxide in Cells and Animals Angew. Chem. Int. Ed. 2020 59 14326 14330 10.1002/anie.202005429
Huo M. Wang L. Chen Y. Shi J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery Nat. Commun. 2017 8 357 10.1038/s41467-017-00424-8
Feng W. Han X. Wang R. Gao X. Hu P. Yue W. Chen Y. Shi J. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows Adv. Mater. 2019 31 1805919 10.1002/adma.201805919
Dong S. Dong Y. Jia T. Zhang F. Wang Z. Feng L. Sun Q. Gai S. Yang P. Sequential Catalytic, Magnetic Targeting Nanoplatform for Synergistic Photothermal and NIR-Enhanced Chemodynamic Therapy Chem. Mater. 2020 32 9868 9881 10.1021/acs.chemmater.9b05170
Zhao Z. Wang W. Li C. Zhang Y. Yu T. Wu R. Zhao J. Liu Z. Liu J. Yu H. Reactive Oxygen Species–Activatable Liposomes Regulating Hypoxic Tumor Microenvironment for Synergistic Photo/Chemodynamic Therapies Adv. Funct. Mater. 2019 29 1905013 10.1002/adfm.201905013
Chen Q. Zhou J. Chen Z. Luo Q. Xu J. Song G. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy ACS Appl. Mater. Interfaces 2019 11 30551 30565 10.1021/acsami.9b09323 31397998
Pignatello J.J. Oliveros E. MacKay A. Advanced Oxidation Processes for Organic Contaminant Destruction Based on the Fenton Reaction and Related Chemistry Crit. Rev. Environ. Sci. Technol. 2006 36 1 84 10.1080/10643380500326564
Shi L. Wang Y. Zhang C. Zhao Y. Lu C. Yin B. Yang Y. Gong X. Teng L. Liu Y. et al. An Acidity-Unlocked Magnetic Nanoplatform Enables Self-Boosting ROS Generation through Upregulation of Lactate for Imaging-Guided Highly Specific Chemodynamic Therapy Angew. Chem. Int. Ed. 2021 60 9562 9572 10.1002/anie.202014415 33590957
Liu Y. Ji X. Tong W.W.L. Askhatova D. Yang T. Cheng H. Wang Y. Shi J. Engineering Multifunctional RNAi Nanomedicine to Concurrently Target Cancer Hallmarks for Combinatorial Therapy Angew. Chem. Int. Ed. 2018 57 1510 1513 10.1002/anie.201710144
Li M. Huo L. Zeng J. Zhu G. Shi S. Liu X. Zhu X. Huang G. Qiu D. Jia J. et al. Surface engineered iron oxide nanozyme for synergistic chemodynamic/photodynamic therapy with glutathione depletion and hypoxia relief Chem. Eng. J. 2022 440 135966 10.1016/j.cej.2022.135966
Chen T. Chu Q. Li M. Han G. Li X. Fe3O4@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy J. Nanobiotechnol. 2021 19 206 10.1186/s12951-021-00957-7
Ma X. Wang Y. Liu X.-L. Ma H. Li G. Li Y. Gao F. Peng M. Fan H.M. Liang X.-J. Fe3O4–Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment Nanoscale Horiz. 2019 4 1450 1459 10.1039/C9NH00233B
Pinto A. Pocard M. Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: A systematic review Pleura Peritoneum 2018 3 20180124 10.1515/pp-2018-0124
Sztandera K. Gorzkiewicz M. Klajnert-Maculewicz B. Nanocarriers in photodynamic therapy—In vitro and in vivo studies WIREs Nanomed. Nanobiotechnol. 2020 12 e1509 10.1002/wnan.1599
Lan M. Zhao S. Liu W. Lee C. Zhang W. Wang P. Photosensitizers for Photodynamic Therapy Adv. Healthc. Mater. 2019 8 1900132 10.1002/adhm.201900132
Fan W. Huang P. Chen X. Overcoming the Achilles’ heel of photodynamic therapy Chem. Soc. Rev. 2016 45 6488 6519 10.1039/C6CS00616G
Mfouo-Tynga I.S. Dias L.D. Inada N.M. Kurachi C. Features of third generation photosensitizers used in anticancer photodynamic therapy: Review Photodiagn. Photodyn. Ther. 2021 34 102091 10.1016/j.pdpdt.2020.102091
Li B. Lin L. Internal light source for deep photodynamic therapy Light Sci. Appl. 2022 11 85 10.1038/s41377-022-00780-1
Plaetzer K. Krammer B. Berlanda J. Berr F. Kiesslich T. Photophysics and photochemistry of photodynamic therapy: Fundamental aspects Lasers Med. Sci. 2009 24 259 268 10.1007/s10103-008-0539-1
Fisher C. Ali Z. Detsky J. Sahgal A. David E. Kunz M. Akens M. Chow E. Whyne C. Burch S. et al. Photodynamic Therapy for the Treatment of Vertebral Metastases: A Phase I Clinical Trial Clin. Cancer Res. 2019 25 5766 5776 10.1158/1078-0432.CCR-19-0673
Zhi D. Yang T. Yang J. Fu S. Zhang S. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy Acta Biomater. 2020 102 13 34 10.1016/j.actbio.2019.11.027
Li T.-F. Xu H.-Z. Xu Y.-H. Yu T.-T. Tang J.-M. Li K. Wang C. Peng X.-C. Li Q.-R. Sang X.-Y. et al. Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma Mol. Pharm. 2021 18 3601 3615 10.1021/acs.molpharmaceut.1c00510
Estelrich J. Busquets M. Iron Oxide Nanoparticles in Photothermal Therapy Molecules 2018 23 1567 10.3390/molecules23071567
Chinnathambi S. Shirahata N. Recent advances on fluorescent biomarkers of near-infrared quantum dots for in vitro and in vivo imaging Sci. Technol. Adv. Mater. 2019 20 337 355 10.1080/14686996.2019.1590731 31068983
Lyu Y. Li J. Pu K. Second Near-Infrared Absorbing Agents for Photoacoustic Imaging and Photothermal Therapy Small Methods 2019 3 1900553 10.1002/smtd.201900553
Lozano-Pedraza C. Plaza-Mayoral E. Espinosa A. Sot B. Serrano A. Salas G. Blanco-Andujar C. Cotin G. Felder-Flesch D. Begin-Colin S. et al. Assessing the parameters modulating optical losses of iron oxide nanoparticles under near infrared irradiation Nanoscale Adv. 2021 3 6490 6502 10.1039/D1NA00601K 36133493
Amatya R. Hwang S. Park T. Min K.A. Shin M.C. In Vitro and In Vivo Evaluation of PEGylated Starch-Coated Iron Oxide Nanoparticles for Enhanced Photothermal Cancer Therapy Pharmaceutics 2021 13 871 10.3390/pharmaceutics13060871 34204840
Dheyab M.A. Aziz A.A. Jameel M.S. Khaniabadi P.M. Mehrdel B. Khaniabadi B.M. Gold-coated iron oxide nanoparticles as a potential photothermal therapy agent to enhance eradication of breast cancer cells J. Phys. Conf. Ser. 2020 1497 012003 10.1088/1742-6596/1497/1/012003
Wang J. Mei T. Liu Y. Zhang Y. Zhang Z. Hu Y. Wang Y. Wu M. Yang C. Zhong X. et al. Dual-targeted and MRI-guided photothermal therapy via iron-based nanoparticles-incorporated neutrophils Biomater. Sci. 2021 9 3968 3978 10.1039/D1BM00127B
Alterio D. Marvaso G. Ferrari A. Volpe S. Orecchia R. Jereczek-Fossa B.A. Modern radiotherapy for head and neck cancer Semin. Oncol. 2019 46 233 245 10.1053/j.seminoncol.2019.07.002
Cheng M. Jolly S. Quarshie W.O. Kapadia N. Vigneau F.D. Kong F.-M. Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 Patients J. Cancer 2019 10 168 177 10.7150/jca.26600
Brown S. Banfill K. Aznar M.C. Whitehurst P. Faivre Finn C. The evolving role of radiotherapy in non-small cell lung cancer Br. J. Radiol. 2019 92 20190524 10.1259/bjr.20190524
Biau J. Chautard E. Verrelle P. Dutreix M. Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting Front. Oncol. 2019 9 1009 10.3389/fonc.2019.01009
Hall S. Rudrawar S. Zunk M. Bernaitis N. Arora D. McDermott C. Anoopkumar-Dukie S. Protection against Radiotherapy-Induced Toxicity Antioxidants 2016 5 22 10.3390/antiox5030022
Huang R.-X. Zhou P.-K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer Sig. Transduct. Target. Ther. 2020 5 60 10.1038/s41392-020-0150-x
Reisz J.A. Bansal N. Qian J. Zhao W. Furdui C.M. Effects of Ionizing Radiation on Biological Molecules—Mechanisms of Damage and Emerging Methods of Detection Antioxid. Redox Signal. 2014 21 260 292 10.1089/ars.2013.5489
Catalá A. Díaz M. Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes Front. Physiol. 2016 7 423 10.3389/fphys.2016.00423
Ye L.F. Chaudhary K.R. Zandkarimi F. Harken A.D. Kinslow C.J. Upadhyayula P.S. Dovas A. Higgins D.M. Tan H. Zhang Y. et al. Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers ACS Chem. Biol. 2020 15 469 484 10.1021/acschembio.9b00939
Jiang H. Wang H. De Ridder M. Targeting antioxidant enzymes as a radiosensitizing strategy Cancer Lett. 2018 438 154 164 10.1016/j.canlet.2018.09.004
Jia S. Ge S. Fan X. Leong K.W. Ruan J. Promoting reactive oxygen species generation: A key strategy in nanosensitizer-mediated radiotherapy Nanomedicine 2021 16 759 778 10.2217/nnm-2020-0448
De Kruijff R.M. FLASH radiotherapy: Ultra-high dose rates to spare healthy tissue Int. J. Radiat. Biol. 2020 96 419 423 10.1080/09553002.2020.1704912
Lacas B. Bourhis J. Overgaard J. Zhang Q. Grégoire V. Nankivell M. Zackrisson B. Szutkowski Z. Suwiński R. Poulsen M. et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis Lancet Oncol. 2017 18 1221 1237 10.1016/S1470-2045(17)30458-8
Hegemann N.-S. Guckenberger M. Belka C. Ganswindt U. Manapov F. Li M. Hypofractionated radiotherapy for prostate cancer Radiat. Oncol. 2014 9 275 10.1186/s13014-014-0275-6
Hughes J.R. Parsons J.L. FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy Int. J. Mol. Sci. 2020 21 6492 10.3390/ijms21186492 32899466
Mohan R. Grosshans D. Proton therapy—Present and future Adv. Drug Deliv. Rev. 2017 109 26 44 10.1016/j.addr.2016.11.006 27919760
Howard D. Sebastian S. Le Q.V.-C. Thierry B. Kempson I. Chemical Mechanisms of Nanoparticle Radiosensitization and Radioprotection: A Review of Structure-Function Relationships Influencing Reactive Oxygen Species Int. J. Mol. Sci. 2020 21 579 10.3390/ijms21020579 31963205
Liu Y. Zhang P. Li F. Jin X. Li J. Chen W. Li Q. Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells Theranostics 2018 8 1824 1849 10.7150/thno.22172 29556359
Peukert D. Kempson I. Douglass M. Bezak E. Metallic nanoparticle radiosensitisation of ion radiotherapy: A review Phys. Med. 2018 47 121 128 10.1016/j.ejmp.2018.03.004
Abdul Rashid R. Zainal Abidin S. Khairil Anuar M.A. Tominaga T. Akasaka H. Sasaki R. Kie K. Abdul Razak K. Pham B.T.T. Hawkett B.S. et al. Radiosensitization effects and ROS generation by high Z metallic nanoparticles on human colon carcinoma cell (HCT116) irradiated under 150 MeV proton beam OpenNano 2019 4 100027 10.1016/j.onano.2018.100027
Choi J. Kim G. Cho S.B. Im H.-J. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme J. Nanobiotechnol. 2020 18 122 10.1186/s12951-020-00684-5
Talik Sisin N.N. Abdul Razak K. Zainal Abidin S. Che Mat N.F. Abdullah R. Ab Rashid R. Khairil Anuar M.A. Mohd Zainudin N.H. Tagiling N. Mat Nawi N. et al. Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy Int. J. Nanomed. 2019 14 9941 9954 10.2147/IJN.S228919
Vilotte F. Jumeau R. Bourhis J. High Z nanoparticles and radiotherapy: A critical view Lancet Oncol. 2019 20 e557 10.1016/S1470-2045(19)30579-0
Guerra D.B. Oliveira E.M.N. Sonntag A.R. Sbaraine P. Fay A.P. Morrone F.B. Papaléo R.M. Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photons Sci. Rep. 2022 12 9602 10.1038/s41598-022-13368-x
Hwang C. Kim J.M. Kim J. Influence of concentration, nanoparticle size, beam energy, and material on dose enhancement in radiation therapy J. Radiat. Res. 2017 58 405 411 10.1093/jrr/rrx009
Emerit J. Beaumont C. Trivin F. Iron metabolism, free radicals, and oxidative injury Biomed. Pharmacother. 2001 55 333 339 10.1016/S0753-3322(01)00068-3
Hauser A.K. Mitov M.I. Daley E.F. McGarry R.C. Anderson K.W. Hilt J.Z. Targeted iron oxide nanoparticles for the enhancement of radiation therapy Biomaterials 2016 105 127 135 10.1016/j.biomaterials.2016.07.032
Klein S. Kızaloğlu M. Portilla L. Park H. Rejek T. Hümmer J. Meyer K. Hock R. Distel L.V.R. Halik M. et al. Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy Small 2018 14 1704111 10.1002/smll.201704111
He C. Jiang S. Jin H. Chen S. Lin G. Yao H. Wang X. Mi P. Ji Z. Lin Y. et al. Mitochondrial electron transport chain identified as a novel molecular target of SPIO nanoparticles mediated cancer-specific cytotoxicity Biomaterials 2016 83 102 114 10.1016/j.biomaterials.2016.01.010
Caffo O. Radiosensitization with chemotherapeutic agents Lung Cancer 2001 34 81 90 10.1016/S0169-5002(01)00382-8
Vaugier L. Mirabel X. Martel-Lafay I. Racadot S. Carrie C. Vendrely V. Mahé M.-A. Senellart H. Raoul J.-L. Campion L. et al. Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer Cancers 2021 13 248 10.3390/cancers13020248
Al-Ejeh F. Shi W. Miranda M. Simpson P.T. Vargas A.C. Song S. Wiegmans A.P. Swarbrick A. Welm A.L. Brown M.P. et al. Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor J. Nucl. Med. 2013 54 913 921 10.2967/jnumed.112.111534
Groen H.J.M. van der Leest A.H.W. Fokkema E. Timmer P.R. Nossent G.D. Smit W.J.G.M. Nabers J. Hoekstra H.J. Hermans J. Otter R. et al. Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: A multicenter phase III study Ann. Oncol. 2004 15 427 432 10.1093/annonc/mdh100
Popescu R.C. Savu D.I. Bierbaum M. Grbenicek A. Schneider F. Hosser H. Vasile B.Ș. Andronescu E. Wenz F. Giordano F.A. et al. Intracellular Delivery of Doxorubicin by Iron Oxide-Based Nano-Constructs Increases Clonogenic Inactivation of Ionizing Radiation in HeLa Cells Int. J. Mol. Sci. 2021 22 6778 10.3390/ijms22136778 34202550
Kang S.H. Hong S.P. Kang B.S. Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel Int. J. Radiat. Biol. 2018 94 1006 1016 10.1080/09553002.2018.1495854 30032692
Stanković A. Mihailović J. Mirković M. Radović M. Milanović Z. Ognjanović M. Janković D. Antić B. Mijović M. Vranješ-Đurić S. et al. Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to 131I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer Int. J. Pharm. 2020 587 119628 10.1016/j.ijpharm.2020.119628 32681867
Żuk M. Podgórski R. Ruszczyńska A. Ciach T. Majkowska-Pilip A. Bilewicz A. Krysiński P. Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment Pharmaceutics 2022 14 1680 10.3390/pharmaceutics14081680
Lin H. Yin L. Chen B. Ji Y. Design of functionalized magnetic silica multi-core composite nanoparticles for synergistic magnetic hyperthermia/radiotherapy in cancer cells Colloids Surf. B Biointerfaces 2022 219 112814 10.1016/j.colsurfb.2022.112814
